slides - Spatial Database Group
Download
Report
Transcript slides - Spatial Database Group
Database Design for Clinical Trial
Xiaoqing He & Gilsinia Lopez
[1,2]
Goals
Build an essential online resource for
tracking side effects of $1 trillion worth
of prescription meds sold around the
world
Applications for both healthcare
professionals and patients
Increase transparency throughout the
healthcare and pharmaceutical industries
Current status
75 % data capture – paper based
Data inconsistencies
Data Entry error
Only 10 percent of data are reported
Solution
Electronic data capture – eCRF
Problems with eCRF
Incomplete
Filled with misspelling
Misclassification
Out of date
Adverse Events Inc. (RxFilter ™)
RxFilter – 17 step data normalization
process
Normalizes the FDA’s adverse events
reports into a single report, and
standardizes the data for improved
accuracy of adverse drug event
information
Achievements and Claims of
Adverse Events Inc.
Lamictal and Keppra, which are classified as
may be “as dangerous to a fetus as drugs
currently listed” should be placed in a more
risky category
measure medication side effects and
ensure high quality standards to protect
patient safety
supports companies with competitive
intelligence and data to inform drug
marketing decisions and business
development strategies.
Relationship With Course
Relevant to chapters of Conceptual modeling
and Relational Database Design
Data collecting, Standardizes and Normalizes
the data
Basic of Functional Dependencies and
Normalization
Reference
[1]Luke Timmerman, Biotech, Startups, IT, Sep. 2011,
http://www.xconomy.com/san-francisco/2011/09/27/adverseevents-comseeks-to-keep-track-of-drug-side-effects-the-way-the-fda-never-could/
[2]Business Wire, Sep. 2011,
http://www.businesswire.com/news/home/20110926005053/en/AdverseE
vents-Launches-Innovative-Comparative-Drug-Side-Effect
[3]Picture 3-6 is from
http://adverseevents.com/drugdetail.php?AEDrugID=807&BrandName=LI
PITOR
[4]Picture 1 is from http://www.drofdetox.com/overview-of-clinical-trial/
[5]Picture 2 is from http://www.ecrf.biz.pl/about_en.htm